
Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

